OBJECTIVE: Complete blood count parameters are frequently altered in COVID-19 patients.
Leucopenia and lymphopenia are the most common findings. This is not specific to COVID …

Background: Since the start of the coronavirus disease 2019 (COVID-19) pandemic, there is
an urgent need for effective therapies for patients with COVID-19. In this study, we aimed to …

Lacticaseibacillus rhamnosus CRL1505 beneficially modulates the inflammation-
coagulation response during respiratory viral infections. This study evaluated the capacity of …

Abstract The COVID-19 (coronavirus disease 2019) is a well-defined viral infection, resulting
from SARS-CoV-2 (severe acute respiratory syndrome-coronavirus-2). The innate immune …

COVID-19 is a disease with a spectrum of clinical responses ranging from moderate to
critical. To study and control its effects, a large number of researchers are focused on two …

Abstract Coronavirus Disease 2019 (COVID‐19) has become a global pandemic in 2020
with high patient mortality due to acute respiratory distress syndrome which is possibly …

Respiratory viral infections are one of the major causes of illness and death worldwide.
Symptoms associated with respiratory infections can range from mild to severe, and there is …

Coronavirus disease 2019 (COVID-19) has emerged as a global health threat.
Unfortunately, there are very limited approved therapeutics available with established …

Reduced awareness of neuropsychological disorders (ie, anosognosia) is a striking
symptom of post-COVID-19 condition. Some leukocyte markers in the acute phase may …

Monocytes play a critical role in inflammation and immune response, their activity being sex‐
dependent. However, the basis of sex differences is not well understood. Therefore, we …